Neuropathology of non-motor features of Parkinson disease.
about
LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative studyBrain-gut-microbiota axis in Parkinson's diseaseSystems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor SystemThe contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's diseaseLipid pathway alterations in Parkinson's disease primary visual cortexThe role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging studyNeuropsychiatric characteristics of GBA-associated Parkinson disease.Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease.First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutationColonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms.The neurobiological basis of cognitive impairment in Parkinson's disease.The management of gastrointestinal symptoms in Parkinson's disease.Neurologists' diagnostic accuracy of depression and cognitive problems in patients with parkinsonismLewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.Differentiating non-motor symptoms in Parkinson's disease from controls and hemifacial spasm.Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease.A family with Parkinsonism, essential tremor, restless legs syndrome, and depression.The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up.Gut microbiota are related to Parkinson's disease and clinical phenotype.Critical aspects of clinical trial design for novel cell and gene therapies.Transmission of Synucleinopathies in the Enteric Nervous System of A53T Alpha-Synuclein Transgenic MiceAlteration of Brain Functional Networks in Early-Stage Parkinson's Disease: A Resting-State fMRI Study.WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.Magnetization transfer and adiabatic R 1ρ MRI in the brainstem of Parkinson's diseaseEntorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementiaA novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.Looking beyond the brain to improve the pathogenic understanding of Parkinson's disease: implications of whole transcriptome profiling of Patients' skin.Clinical and neuroimaging characteristics of Chinese dementia with Lewy bodies.Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.A pilot study on the benefit of cognitive rehabilitation in Parkinson's disease.Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease.Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's diseaseNeuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.α-Synuclein and dopamine at the crossroads of Parkinson's diseaseGene therapy: a viable therapeutic strategy for Parkinson's disease?Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.Brain banks as key part of biochemical and molecular studies on cerebral cortex involvement in Parkinson's disease.Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis
P2860
Q24307455-34521A5F-C7F6-4319-8817-3F1A99A2A355Q26784403-B452F970-2C7F-4457-B837-49C61BBB81D7Q26999386-AD9F5E9B-111A-476A-9AC8-541EBAA21CEEQ28068464-95B6005C-D0A9-45D6-88C1-2DD9FC06E7E5Q28386548-1849F429-E3E2-45C2-8AF3-680CAAA5550FQ28727519-FA224940-8A87-4922-A529-C7E4E41E2C10Q30275630-6A96EEB0-FAF9-4746-A41C-0B697573D448Q30446890-CBAA2BE4-55E6-4A43-AE7E-4397CC4A92D4Q30513503-EE952306-2E9C-4CD5-850C-A680910DBE27Q33697904-1A47C65E-EBD0-453D-9277-29D40892884EQ33724698-5EE2C051-63D1-49DB-A320-6CB3A59B4D93Q34250597-F3EE5226-AEE1-4596-A29B-646070A50689Q34306196-0720F409-68D6-43FA-B864-92090B84487FQ34327102-9BC541D0-5D78-4F99-9FF6-6A9298F7164BQ34470963-087148A2-76A7-4AB6-B3F5-539524A29E23Q34585803-9E1366B3-BE37-4843-8C81-E5A79455A16DQ34591096-8C85FA7C-BA31-40AC-9E7D-A0BC009C81D0Q34999207-38516C67-1163-4EF3-978D-F161395EAC68Q35098556-678B0C2E-3CBF-4D4E-842F-A0E76193A923Q35492461-5B4F93C0-27F8-4EFB-8B93-E1C20F4899FBQ35664438-BD3302C7-204A-4DF7-809C-A848F8BA1F16Q35707907-35949A41-74B5-47C5-BDCC-00D207EB8AEDQ35827114-7EC257C2-E8C5-48C6-9D07-5A0D2272C4A6Q35878214-04AB13CA-A564-4CFA-85AE-101F75403A9BQ35977276-4EF9043E-1CFA-436F-8323-EAA8C6489CDCQ36004081-299CA616-318E-4CF2-BB45-1579534B3A70Q36109452-840B1930-B06F-4F36-9E0A-91291A43C6FAQ36244619-B7DCB972-E44D-493E-B459-FF52E9FDEDE3Q36295239-2B43927B-BE70-484F-9CCA-42A50332AF7DQ36351543-D906245E-AD6A-4FC7-ACE0-CA5C54C8BFCFQ36581696-B8E1D9F7-6896-4B68-8940-2D3391C5E27AQ36737558-B69CCE4C-C887-43EA-BA0E-8FD0AB055B09Q37016546-BABB910E-4AB1-47CA-A1FA-C086C0C56278Q37062735-FC6CE681-F8B9-4D18-974F-364A6730FBD3Q37693339-FCC3C28F-8690-4709-9430-1030010C37CEQ37801701-3AB21F80-F62E-4ABE-8763-01C9FAC3A49AQ37801855-41EA923A-E3E3-46B9-B02F-B89A000984D0Q37955871-2E5073CD-D313-47E7-86CD-17E879704C54Q37982151-F4F32E0A-DA74-42FC-929A-1826188A50A2Q37982715-26DAFAC5-F07E-48A6-8978-5AAF2AE63546
P2860
Neuropathology of non-motor features of Parkinson disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuropathology of non-motor features of Parkinson disease.
@en
Neuropathology of non-motor features of Parkinson disease.
@nl
type
label
Neuropathology of non-motor features of Parkinson disease.
@en
Neuropathology of non-motor features of Parkinson disease.
@nl
prefLabel
Neuropathology of non-motor features of Parkinson disease.
@en
Neuropathology of non-motor features of Parkinson disease.
@nl
P2093
P50
P1476
Neuropathology of non-motor features of Parkinson disease.
@en
P2093
Anthony DelleDonne
Hiroshige Fujishiro
Joseph E Parisi
Keith A Josephs
Kevin J Klos
Melinda Burnett
Roberta Frigerio
P356
10.1016/S1353-8020(09)70769-2
P478
15 Suppl 3
P577
2009-12-01T00:00:00Z